Ruslan Averin on UNH, BA, CCL and NCLH: Four Broken Stocks, Four Different Answers
Independent analyst breaks down why four similarly damaged stocks require four completely different approaches in May 2026.
Kyiv, Ukraine, 23rd May 2026 – Not all damaged stocks recover the same way. Some reprice and move on. Some reprice and keep falling. The difference matters more than the discount.
Ruslan Averin, an independent analyst covering equity markets and derivatives strategies, who tracks all four names actively in his own research portfolio, published research in May 2026 examining four stocks that have spent the past two years under significant pressure — and why he sees them differently.
UnitedHealth Group (NYSE: UNH) reported Q1 2026 earnings of $7.23 per share, ahead of estimates, with its Medical Care Ratio falling 0.9 percentage points to 83.9%. The company raised full-year guidance above $18.25 EPS. “UNH is a turnaround that is actually turning,” Averin said. “At 18-19 times forward earnings for a company with $111 billion in quarterly revenue, the valuation is the most compelling it has been in years. The damage from 2024-2025 is priced in. The recovery is not.”
Boeing (NYSE: BA) presents a different calculation. The company carries a $682 billion order backlog — structural demand that is not in question. The question is execution. With $54 billion in debt and free cash flow guidance of $1-3 billion for 2026, there is little room for operational errors. “Boeing is a buy when quarterly deliveries confirm the path to 700+ aircraft for 2026. Until then, the backlog is a promise, not a result,” Averin noted. “I watch the delivery numbers every quarter.”
On the cruise sector, Averin draws a clear distinction between Carnival Corporation (NYSE: CCL) and Norwegian Cruise Line (NYSE: NCLH). Both stocks bounced sharply this week — CCL up 9%, NCLH up 11% — but he sees them differently at current levels. “CCL has the stronger balance sheet, the better cash flow trajectory, and the private destination infrastructure that gives it pricing power NCLH does not have,” he said. “Norwegian’s 40% capacity expansion in the Caribbean creates a supply problem in a market that is already price-sensitive. Goldman downgraded it for a reason. For anyone holding NCLH hoping for a quick recovery to pre-2024 levels, that supply dynamic is the reason to reconsider the timeline.”
His framework for all four comes down to one question: is the damage structural or cyclical? “UNH had an event-driven selloff. BA had an execution problem it is fixing. CCL had a leverage problem it has largely addressed. NCLH has a competitive positioning problem that more capacity does not solve,” Averin said. “Those are four different situations that happened to produce four similar-looking charts. The charts are not the story.”
Averin’s equity research and options commentary are published at averin.com, covering market structure, derivatives strategies, and individual stock analysis.
About Ruslan Averin:
Ruslan Averin is an independent analyst covering equity markets, options strategies, and macroeconomic signals. Founder of averin.com.
Company Details
Organization: averin.com
Contact Person: Ruslan Averin
Website: https://averin.com
Email: Send Email
City: Kyiv
Country: Ukraine
Release Id: 23052645376
Disclaimer: This content is provided for informational and educational purposes only and does not constitute investment, financial, legal, or trading advice. The views expressed are those of the author and are based on publicly available information and personal analysis at the time of writing. Readers should conduct their own research or consult a qualified professional before making any investment decisions.